Semaglutide
Wegovy is an FDA-approved semaglutide product with injection and tablet presentations. The current label describes different weight-management populations for the two forms. Read the product comparison and the official Wegovy label.
Medical weight management
Understand the evaluation, the medication options, and the questions to ask before treatment. A licensed healthcare professional decides whether a medication is appropriate for you.
Read the guide to online GLP-1 careEducational information. Individual clinical decisions.
Before you decide
A health form starts a review. It does not confirm eligibility or guarantee a prescription. Your medical history, other medicines, the exact product, and the follow-up plan all matter.
Semaglutide and tirzepatide are different ingredients. A familiar ingredient name does not tell you a preparation's FDA approval status, route, indication, or safety instructions.
Wegovy is an FDA-approved semaglutide product with injection and tablet presentations. The current label describes different weight-management populations for the two forms. Read the product comparison and the official Wegovy label.
Zepbound is an FDA-approved tirzepatide injection with its own adult indications, contraindications, warnings, and instructions. Discuss the exact product with a clinician. See the official Zepbound label.
Compounded drugs are not FDA-approved. Their ingredients and route must not be used to imply the approval or evidence of a branded product. Read FDA-approved versus compounded medications and FDA's patient guidance.
Wegovy and Zepbound labels carry boxed warnings about thyroid C-cell tumors seen in rodents; it is unknown whether these drugs cause these tumors in humans. They are contraindicated with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. The labels contain other warnings and contraindications. Discuss pregnancy, contraception, other medicines, and your medical history with the clinician.
Cost and insurance
A consultation, medication, laboratory tests, supplies, and shipping can have separate costs. Visit coverage does not establish medication coverage. Confirm a provider's current price, inclusions, renewal rules, and refund terms before paying.
The care steps
A licensed healthcare professional reviews the information needed for a decision. More information, tests, a live visit, in-person care, or another treatment may be appropriate.
If prescribed, medication still requires pharmacy review and fulfillment. Availability, payment, coverage, product checks, and shipment are separate steps.
Follow-up gives you a chance to report side effects and discuss treatment. A refill request is reviewed separately; monitoring and labs depend on the individual plan.
Read what an evaluation may include, the pharmacy steps, and refills and follow-up.
Common questions
No. Intake is followed by a clinical evaluation. A licensed clinician decides whether a treatment or prescription is appropriate.
No. FDA does not review compounded drugs for safety, effectiveness, or quality before marketing. Approval of a branded product does not transfer to a compounded preparation.
No. Different products have different routes and instructions, including FDA-approved oral semaglutide tablets. Ask for the exact product, dosage form, and approval status.
Weight loss during pregnancy offers no benefit and can pose fetal risk. Discuss pregnancy or pregnancy plans with the prescriber promptly and follow the specific product's safety instructions. Semaglutide and tirzepatide labels contain product-specific pregnancy and contraception guidance.
Follow your medication's safety instructions. Seek urgent medical care for severe or sudden symptoms, including severe abdominal pain or signs of a serious allergic reaction. Call 911 if you may have a medical emergency. Do not wait for an administrative email or refill message.
Keep your medication list and health history ready. Use the resource library to prepare for the evaluation, cost questions, and follow-up.
Explore the resource library